NCT04752826 · Interventional trial
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Overall registry status Recruiting
Phase 1 · Phase 2
Conditions Advanced Malignancies, Melanoma, Ovarian Cancer, T-cell Lymphoma
Delaware Valley sites
- University of Pennsylvania · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory